Reuters
19 Nov 2026, 08:30 UTC · 11h ago
Holding firm Exor to raise bioMerieux stake to around 8.5%
Impact · against what's priced in
Exor's decision to increase its stake in bioMerieux to 8.5% provides a modest positive signal of institutional confidence. As there is no established baseline for the current pricing of this ownership structure, the move acts as a minor catalyst for BIMER.
- BIMER+0.30
No priced-in read yet
- In context
Exor increasing its stake to approximately 8.5% signals strong institutional confidence and reduces the available float.
Read from the article alone

Search tags




